BOLT vs XEL · rev $31.0K vs P/E 20, $39.33B cap
Bolt Biotherapeutics (BOLT) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported BOLT revenue for 2026-06-30 was $31.0K. Net income was -$15.0M. Revenue was up 19.2% from 2026-03-31 to 2026-06-30. BOLT currently screens at market cap $11.3M.
XEL does not have a complete income-statement cache yet.
BOLT currently screens at market cap $11.3M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the BOLT and XEL stock pages for the full models.
Not investment advice.